Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 35Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 26Neoplasms 16Uterine Cervical Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 10Sarcoma 9Rectal Neoplasms 9Carcinoma, Renal Cell 9Carcinoma, Hepatocellular 9Prostatic Neoplasms 8Neoplasm Metastasis 8Lymphoma 8Brain Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Oropharyngeal Neoplasms 7Multiple Myeloma 7Melanoma 7Head and Neck Neoplasms 7Glioblastoma 7Colorectal Neoplasms 7Urinary Bladder Neoplasms 6Thyroid Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Hodgkin Disease 6Colonic Neoplasms 6Salivary Gland Neoplasms 5Ovarian Neoplasms 5

Interventions

Doxorubicin 18Ifosfamide 13Radiotherapy 8Paclitaxel 7pazopanib 6pembrolizumab 4Gemcitabine 4Filgrastim 4Chemotherapy, Adjuvant 4Bevacizumab 4spartalizumab 3durvalumab 3Sorafenib 3Propranolol 3Nivolumab 3Ipilimumab 3Imatinib Mesylate 3Etoposide 3Epirubicin 3Docetaxel 3Carboplatin 3trebananib 2regorafenib 2cixutumumab 2cemiplimab 2carotuximab 2brostallicin 2belinostat 2balstilimab 2Vincristine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemangiosarcoma × Fluorodeoxyglucose F18 × Clear all
NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Fox Chase Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Sarcoma

Hemangiosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡